European Urology Oncology
European Urology Oncology is part of the European Urology family, which also includes European Urology Focus. It is the first official journal of the European Association of Urology dedicated entirely to the research of genitourinary cancers. This journal strives to provide top-notch research through a collaborative approach that brings together various fields such as Urology, Medical Oncology, Radiation Therapy, Imaging, Pathology, and Basic Research. Its primary focus is to enhance the understanding and treatment of urological cancers. The journal features a range of content, including original research articles, opinion editorials, and invited reviews that span clinical, basic, and translational studies. It is published electronically six times a year. All articles submitted undergo a peer-review process by a group of experts before being accepted for publication. The journal also promotes Open Access for its readers.
Outlet metrics
Global
N/A
Country
N/A
Category
N/A
Articles
-
Mar 13, 2024 |
euoncology.europeanurology.com | David Benjamin |Newport Beach
On October 22, 2023, results from the phase 3 trials EV-302, comparing enfortumab vedotin plus pembrolizumab (EV + P) with chemotherapy, and CheckMate 901, comparing gemcitabine, cisplatin, and nivolumab with chemotherapy alone, in metastatic urothelial carcinoma (mUC) were presented at the European Society for Medical Oncology (ESMO) Congress in Madrid, Spain [1Powles T.B. Perez Valderrama B. Gupta S. et al.
-
May 3, 2018 |
euoncology.europeanurology.com | Alberto Briganti
European Urology Oncology journalists
Contact details
Address
123 Example Street
City, Country 12345
Phone
+1 (555) 123-4567
Email Patterns
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →